10.1038bjc.2017.210.ann

T1 Intervention 849 854 urine
T2 Condition 22 29 bladder
T3 Condition 11 36 Urothelial bladder cancer
T4 Protein 1179 1183 TERT
T5 Protein 574 577 UBC
T6 Protein 951 955 TERT
T7 Disease 736 745 infection
T8 Protein 38 41 UBC
T9 Organism 1123 1131 patients
T10 Protein 377 381 TERT
T11 Protein 1037 1045 P=0.0004
T12 Protein 747 751 TERT
T13 Protein 841 845 TERT
T14 Intervention 159 164 urine
T15 Protein 424 427 UBC
T16 Condition 834 839  situ
T17 Condition 828 832 oma 
T18 Condition 318 336 promoter mutations
T19 Protein 234 239 NMIBC
T20 Organism 90 97 Patient
T21 Organism 484 491 patient
T22 Protein 909 914 NMIBC
T23 Condition 552 559 bladder
T24 Disease 720 732 inflammation
T25 Gene_or_gene_product 1179 1192 TERT mutation
T26 Organism 518 526 patients
T27 Condition 822 826 carc
T28 Protein 1257 1260 UBC
T29 Organism 618 626 patients
T30 Organism 618 625 patient
T31 Protein 276 280 TERT
T32 Protein 1048 1052 TERT
T33 Condition 198 232 non-muscle-invasive bladder cancer
T34 Biomarker 1026 1035 5.34-fold
T35 Gene 242 274 Telomerase reverse transcriptase
T36 Protein 1276 1281 NMIBC
T37 Intervention 1197 1202 urine
T39 Gene_or_gene_product 377 390 TERT mutation
T40 Organism 1123 1130 patient
T41 Intervention 394 399 urine
T42 Organism 518 525 patient
T43 Protein 311 314 UBC
T44 Condition 1184 1193 mutations
T45 Condition 218 225 bladder